Resveratrol as a potential broad-spectrum compound for cancer treatment
There is a need to shift the paradigm of cancer therapeutic approach. The severe adverse side effects, drug resistance
and unaffordable price plagued with chemotherapeutic drugs has spurred the development of “dirty drug”. Natural products,
specifically phytochemicals, have gained much attention due to their ability to target multiple interconnected pathways.
Resveratrol (RSV), the stilbenes found in red wine, is one of the phytochemicals that exhibits various pharmacological
therapeutic effects including cancer. In this review, we highlighted RSV as a potential “broad-spectrum” anticancer compound,
by summarising its targeting mechanisms in the pathways relevant to the cancer hallmarks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher right for the first publication with the work simultaneously licensed under:
Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows for the copying, distribution and transmission of the work, provided the correct attribution of the original creator is stated. Adaptation and remixing are also permitted.
This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types for non-commercial purposes.
The author(s) permits HH Publisher to publish this article that has not been submitted elsewhere.